75. Jahrestagung der Deutschen Gesellschaft für Kardiologie

Donnerstag, 16. April 2009 (Posterbereich A) 09:30-11:00

Postervorträge

Long-QT-Syndrom / Brugada-Syndrom

Diskussionsleiter: R. Schimpf (Mannheim), J. W. Schrickel (Bonn)

(P110) Predictors of atrial tachyarrhythmias in subjects with type 1 ECG pattern of Brugada syndrome.

C. Restle, K. Letsas, R. Weber, J. Stockinger, V.T. Blum, D. Kalusche, T. Arentz (Bad Krozingen)
(P111) Prevalence of early repolarization pattern in inferolateral leads in patients with Brugada syndrome

K. Astheimer, K. Letsas, R. Weber, D. Kalusche, M. Haissaguerre, T. Arentz (Bad Krozingen; Bordeaux-Pessac, FR)
(P112) Brugada like ECG patterns in the German general population

M. F. Sinner, A. Pfeufer, S. Perz, E. Schulze-Bahr, G. Mönnig, L. Eckardt, G. Breithardt, G. Steinbeck, H.-E. Wichmann, C. Gieger, T. Meitinger, L. Fabritz, S. Kääb, P. Kirchhof (München, Neuherberg, Münster)
(P113) Prevalence of Early Repolarization in the German General Population

M. F. Sinner, B. M. Beckmann, W. Reinhard, E. Martens, A. Pfeufer, A. Döring, R. Holle, S. Perz, C. Hengstenberg, S. Kääb (München, Regensburg, Neuherberg)
(P114) Genotyp – Phänotyp Korrelation in einer großen kaukasischen Familie mit der E1784K Mutation im SCN5A Gen

C. G. Veltmann, G. Strupp, R. Schimpf, C. Antzelevitch, F. Streitner, J. Kuschyk, T. Bonzel, M. Borggrefe, C. Wolpert (Mannheim, Fulda; Utica, US)
(P115) Die LQTS-1 assoziierte KCNQ1 Mutation T587M stört die KCNH2 Membranlokalisation und weist einen malignen klinischen Phänotyp auf

P. Biliczki, Z. Girmatsion, R. P. Brandes, I. Baro, S. Nattel, S. Hohnloser, J. Ehrlich (Frankfurt am Main; Nantes, FR; Montreal, CA)
(P116) Isoproterenol Reduces Dispersion of Cardiac Refractoriness in Transgenic LQT2 Rabbits

K. Odening, O. Ziv, B.-R. Choi, G.-X. Liu, M. Kirk, M. Brunner, X. Peng, M. Zehender, G. Koren (Freiburg; Providence, Hershey, US)
(P117) More Pronounced Isoproterenol-induced VERP-shortening Due to Increased IKs Current Densities in Female LQT2 Rabbits Account for Steeper QT/RR Ratio in LQT2 Females

K. Odening, G.-X. Liu, M. Kirk, M. Brunner, L. Schofield, L. Chaves, X. Peng, M. Zehender, G. Koren (Freiburg; Providence, Hershey, US)
(P118) Systematic replication analysis of common genetic variants associated with atrial fibrillation supports two new susceptibility loci

M. F. Sinner, A. Pfeufer, B. M. Beckmann, S. Lubitz, S. Perz, C. Gieger, P. T. Ellinor, S. Kääb (München, Neuherberg; Charlestown, US)
(P119) Preload-reducing therapy prevents development of ARVC in plakoglobin-deficient mice and preserves connexin expression

L. Fabritz, M. Hogendijk, B. P. Sicluna, L. Fortmüller, S. Laakmann, P. Ruiz, H. Witt, T. Wichter, G. Breithardt, J. de Bakker, R. Coronel, P. Kirchhof (Münster, Berlin, Osnabrück; Amsterdam, NL)
(P120) Acute inhibition of the Na+/Ca2+ exchanger by SEA0400 reduces proarrhythmia in an experimental model of chronic heart failure

P. Milberg, C. Pott, G. Frommeyer, M. Paul, G. Breithardt, L. Eckardt (Münster)
(P121) QRS fragmentation in standard ECG as a diagnostic marker of arrhythmogenic right ventricular dysplasia-cardiomyopathy.

S. Peters (Goslar)
(P122) Suppression of triggered activity underlying antitorsadogenic effects of free polyunsaturated fatty acids in long QT syndrome.

P. Milberg, M. Paul, C. Pott, A. Kleideiter, G. Mönnig, G. Breithardt, L. Eckardt (Münster)